![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessPARP inhibitors in the treatment of ovarian cancer
The recent exciting findings on the use of poly(adenosine diphosphate [ADP]-ribose) polymerase inhibitor (PARPi) maintenance therapy in the first-line and later lines of treatment in ovarian cancer are illustr...
-
Article
Open AccessEvaluation of Vav3.1 as prognostic marker in endometrial cancer
Vav3 is a guanine nucleotide exchange factor that regulates the activity of Rho/Rac family GTPases. In a study on ovarian cancer, we recently demonstrated pronounced prognostic and predictive value of Vav3.1, ...
-
Article
Open AccessFatal invasive cervical cancer secondary to untreated cervical dysplasia: a case report
Well-documented cases of untreated cervical intra-epithelial dysplasia resulting in fatal progression of invasive cervical cancer are scarce because of a long pre-invasive state, the availability of cervical c...
-
Article
Urinary neopterin does not reflect the local antitumor immune milieu in ovarian cancer
The main objective of the present investigation was to study the urinary neopterin excretion in the context of the activation of the adaptive cellular immune system at the tumor site. For this purpose, we comp...
-
Article
Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer
This study analyzes the relationship between coxsackie-adenovirus receptor (CAR) expression (transmembrane and soluble isoforms) and hormone sensitivity in 95 breast cancers. Furthermore, prognostic significan...